nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.156	0.171	CbGbCtD
Brompheniramine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0998	0.109	CbGbCtD
Brompheniramine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0868	0.0948	CbGbCtD
Brompheniramine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.08	0.0875	CbGbCtD
Brompheniramine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0584	0.0638	CbGbCtD
Brompheniramine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0431	0.0471	CbGbCtD
Brompheniramine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0431	0.0471	CbGbCtD
Brompheniramine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0389	0.0425	CbGbCtD
Brompheniramine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0358	0.0391	CbGbCtD
Brompheniramine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0358	0.0391	CbGbCtD
Brompheniramine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0327	0.0358	CbGbCtD
Brompheniramine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0327	0.0358	CbGbCtD
Brompheniramine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0292	0.0319	CbGbCtD
Brompheniramine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0275	0.03	CbGbCtD
Brompheniramine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0271	0.0296	CbGbCtD
Brompheniramine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0186	0.0203	CbGbCtD
Brompheniramine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0181	0.0198	CbGbCtD
Brompheniramine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0177	0.0193	CbGbCtD
Brompheniramine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0158	0.0172	CbGbCtD
Brompheniramine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00926	0.0101	CbGbCtD
Brompheniramine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00874	0.00955	CbGbCtD
Brompheniramine—Chlorphenamine—SLC6A4—chronic obstructive pulmonary disease	0.000248	0.384	CrCbGaD
Brompheniramine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.238	CrCbGaD
Brompheniramine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.205	CrCbGaD
Brompheniramine—Promazine—HTR2A—chronic obstructive pulmonary disease	0.000111	0.173	CrCbGaD
Brompheniramine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3e-05	0.000356	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.99e-05	0.000355	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.98e-05	0.000354	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.98e-05	0.000354	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.98e-05	0.000354	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.95e-05	0.00035	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.92e-05	0.000347	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.81e-05	0.000334	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.77e-05	0.000329	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.76e-05	0.000328	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.75e-05	0.000326	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.74e-05	0.000325	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.73e-05	0.000324	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.72e-05	0.000323	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.72e-05	0.000323	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.72e-05	0.000323	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.71e-05	0.000322	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.7e-05	0.000321	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.7e-05	0.00032	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.69e-05	0.00032	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.68e-05	0.000318	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.66e-05	0.000316	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.66e-05	0.000316	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.62e-05	0.000311	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.6e-05	0.000309	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.6e-05	0.000309	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.6e-05	0.000308	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.59e-05	0.000308	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.59e-05	0.000308	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.59e-05	0.000307	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.59e-05	0.000307	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.58e-05	0.000307	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.58e-05	0.000306	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.56e-05	0.000304	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.56e-05	0.000304	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.51e-05	0.000298	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.47e-05	0.000294	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.46e-05	0.000293	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.46e-05	0.000292	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.43e-05	0.000289	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000289	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.41e-05	0.000287	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.38e-05	0.000283	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.37e-05	0.000282	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.37e-05	0.000282	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.37e-05	0.000281	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.34e-05	0.000278	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.32e-05	0.000275	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.31e-05	0.000275	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.29e-05	0.000272	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.27e-05	0.00027	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.24e-05	0.000266	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000266	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.17e-05	0.000258	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.16e-05	0.000257	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.16e-05	0.000257	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.16e-05	0.000256	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.15e-05	0.000256	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.15e-05	0.000255	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.13e-05	0.000253	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000248	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.08e-05	0.000247	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.07e-05	0.000246	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.05e-05	0.000243	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000235	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.97e-05	0.000235	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.96e-05	0.000233	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.96e-05	0.000233	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.94e-05	0.00023	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000229	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.92e-05	0.000229	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.9e-05	0.000226	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.9e-05	0.000226	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.89e-05	0.000225	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.89e-05	0.000225	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.89e-05	0.000224	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.000224	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.88e-05	0.000223	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.87e-05	0.000223	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.87e-05	0.000222	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.84e-05	0.000219	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.81e-05	0.000215	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.81e-05	0.000215	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.000213	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.77e-05	0.00021	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.77e-05	0.00021	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.76e-05	0.00021	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.76e-05	0.000209	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.76e-05	0.000209	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.75e-05	0.000208	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.74e-05	0.000207	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.73e-05	0.000206	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.71e-05	0.000204	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.68e-05	0.0002	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.63e-05	0.000194	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.63e-05	0.000194	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.63e-05	0.000193	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000193	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.62e-05	0.000193	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.61e-05	0.000192	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.61e-05	0.000191	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.61e-05	0.000191	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.61e-05	0.000191	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.00019	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.59e-05	0.000189	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.58e-05	0.000188	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.58e-05	0.000188	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000187	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.57e-05	0.000187	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.55e-05	0.000184	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.48e-05	0.000175	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.47e-05	0.000175	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.47e-05	0.000175	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.47e-05	0.000174	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.46e-05	0.000174	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.46e-05	0.000173	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.46e-05	0.000173	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.45e-05	0.000173	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.45e-05	0.000173	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.45e-05	0.000172	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.45e-05	0.000172	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.44e-05	0.000172	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.44e-05	0.000171	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000171	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.44e-05	0.000171	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.000166	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.38e-05	0.000164	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.38e-05	0.000164	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.000163	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.36e-05	0.000161	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.34e-05	0.000159	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.34e-05	0.000159	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.34e-05	0.000159	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.33e-05	0.000158	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.33e-05	0.000158	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.33e-05	0.000158	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000158	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.32e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.32e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.32e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000156	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.000156	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.31e-05	0.000155	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.28e-05	0.000152	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.000151	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.000151	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.26e-05	0.00015	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.26e-05	0.000149	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.25e-05	0.000148	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.21e-05	0.000144	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.000142	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.19e-05	0.000141	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	0.000141	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.18e-05	0.000141	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.18e-05	0.00014	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.17e-05	0.000139	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.17e-05	0.000139	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000133	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.12e-05	0.000133	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.11e-05	0.000132	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.11e-05	0.000132	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000131	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	1.1e-05	0.000131	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.1e-05	0.000131	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.00013	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.06e-05	0.000126	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.06e-05	0.000126	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000126	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.05e-05	0.000125	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000125	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000124	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.03e-05	0.000122	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000121	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.01e-05	0.00012	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.76e-06	0.000116	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.73e-06	0.000116	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.72e-06	0.000115	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.7e-06	0.000115	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.64e-06	0.000114	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.61e-06	0.000114	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	9.51e-06	0.000113	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.49e-06	0.000113	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.47e-06	0.000113	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.32e-06	0.000111	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	9.31e-06	0.000111	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.29e-06	0.00011	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.26e-06	0.00011	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.17e-06	0.000109	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	9.09e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.07e-06	0.000108	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.91e-06	0.000106	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.89e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.87e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.84e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.75e-06	0.000104	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.75e-06	0.000104	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.69e-06	0.000103	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.52e-06	0.000101	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.33e-06	9.89e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.16e-06	9.7e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	8.05e-06	9.56e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.89e-06	9.37e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.86e-06	9.34e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.84e-06	9.32e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.76e-06	9.22e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	7.7e-06	9.15e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.5e-06	8.91e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.48e-06	8.89e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.45e-06	8.86e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.38e-06	8.77e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.29e-06	8.67e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.19e-06	8.55e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	7.18e-06	8.54e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.16e-06	8.51e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.14e-06	8.48e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.11e-06	8.45e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.09e-06	8.43e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.02e-06	8.34e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	6.87e-06	8.16e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.85e-06	8.14e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.7e-06	7.97e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.61e-06	7.85e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.55e-06	7.79e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	6.55e-06	7.78e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.41e-06	7.61e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.39e-06	7.59e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.37e-06	7.57e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.35e-06	7.55e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.32e-06	7.51e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.31e-06	7.49e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.27e-06	7.46e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.26e-06	7.44e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.88e-06	6.99e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.86e-06	6.97e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.84e-06	6.94e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.79e-06	6.88e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.77e-06	6.85e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.75e-06	6.83e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.73e-06	6.81e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.67e-06	6.74e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.84e-06	5.75e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.83e-06	5.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.81e-06	5.72e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.76e-06	5.66e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.43e-06	5.27e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.42e-06	5.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.4e-06	5.23e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.36e-06	5.18e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.32e-06	5.13e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.13e-06	4.91e-05	CbGpPWpGaD
